China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial Results
November 05 2012 - 8:00AM
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or
the "Company"), a leading China-based biopharmaceutical company
focused on the research, development, manufacture, marketing and
sales of hospital-based medical products, today announced that the
Company plans to release third quarter 2012 financial results on
Sunday, November 25, 2012 .
The Company will hold a conference call at 8:00 a.m. ET on
Monday, November 26 to discuss third quarter 2012 results.
Listeners may access the call by dialing:
United States toll free: |
1-855-500-8701 |
China toll free: |
400-1200654 |
Hong Kong toll free: |
800-903737 |
United Kingdom toll free: |
0800-0159724 |
International: |
65-6723-9385 |
Conference ID: |
64309501 |
A live webcast and replay of the earnings call will be available
through the Company's website www.nkbp.com.
About China Nuokang Bio-Pharmaceutical
Inc.
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading
biopharmaceutical company in China focused on the research,
development, manufacture, marketing and sales of hospital-based
medical products. The Company provides a diversified portfolio of
products across more than 4,200 hospitals in China. Nuokang's
principal products include Baquting®, China's leading hemocoagulase
product by market share; Kaitong®, a lipid emulsion alprostadil
product for the treatment of peripheral vascular diseases,
cardiocerebral microcirculation disorders and post-surgery
thrombosis; and alpha lipoic acid capsules, or ALA, an antioxidant
product that addresses diabetic neuropathy. The Company's product
pipeline includes product candidates under development in
hematological, cardiovascular and cerebrovascular disease
diagnosis, treatment and prevention. Please visit www.nkbp.com for
more information.
CONTACT: China Nuokang Bio-Pharmaceutical Inc.
Mr. Steven Duan
Vice President of Investor Relations
Email: dsz@nkbp.com
ICR, Inc.
Mr. Rob Koepp
Tel: (+86) 10-6583-7516 or (646) 405-5180
Email: robert.koepp@icrinc.com
China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ:NKBP)
Historical Stock Chart
From May 2024 to Jun 2024
China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ:NKBP)
Historical Stock Chart
From Jun 2023 to Jun 2024